IU School of Medicine researchers discover combination drug for TNBC

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Researchers at Indiana University School of Medicine and IU Simon Comprehensive Cancer Center have developed a novel antibody-drug conjugate for treating triple negative breast cancer.

To access this subscriber-only content please log in or renew you subscription.

Looking for IP Login? Our IP Login system is now automatic. If your institution has a site license, please log in from on site or via your VPN to access this content.

Login Subscribe
In This Issue

YOU MAY BE INTERESTED IN

Login